Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyphenon E for Actinic Keratosis
NCT00005097Phase 2Terminated
- Start
- Aug 1999
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of green tea extract in actinic keratosis (AK). Started Aug 1999; status: terminated.
02
Drugs
green tea extract
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00005097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005097.